In the study herein, we found that tumor cell-intrinsic KRT19 deficiency results in cell cycle arrest in G1 phase and the accumulation of SA-β-gal, thus directly suppressing NSCLC progression ultimately. The gene discussed is KRT19; the disease is neoplasm.